Germany Suspends Takeda Diabetes Drug Actos
The announcement from Germany's Federal Institute for Drugs and Medical Devices follows France's decision Thursday to suspend use of drugs containing pioglitazone, based on testing in that country showing increased bladder cancer risks.
That suspension includes Takeda's Competact-brand drug, which is a combination of pioglitazone and metformin. Both Actos and Competact are...
To view the full article, register now.